HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Health (OTC Drugs)

Set Alert for Health (OTC Drugs)

Regulation/Legislation Explore this Topic

Set Alert for Regulation and Legislation {Health}

Latest From Regulation, Legislation & Health

False Documents Land Chinese OTC Firm In Real Regulatory Trouble With US FDA

As HBW Insight reported, following inspection in March, FDA placed Huize Commodity's hand sanitizers, sunscreens and lip balms on import alert in June. During FDA inspection, "multiple documents provided were in fact falsified," according to warning.
OTC Drugs Commercial

NRT Delivery Innovation Proposal In US Doesn't Deliver Expanded Indications

GSK's proposed usage for mouth spray product – reducing withdrawal symptoms, including nicotine craving – differs little from the first NRT product approved in US in 1984. Additional suggested label instructions primarily focus on stating NRTs can be used to reduce smoking or gradually stop tobacco use as opposed to quitting within a specified amount of time.

OTC Drugs Regulation

Health And Wellness Product Trademark Review 13 August, 2019

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
OTC Drugs Dietary Supplements

GSK Proposes Adding OTC Oral Spray To US Smoking Cessation Sector

FDA schedules Nonprescription Drugs Advisory Committee meeting 18 September to consider GSK's NDA for an OTC nicotine oral spray that delivers 1mg per spray.
Europe International

Switching Can Help Normalize Self-Care – PAGB’s Michelle Riddalls

Automatic switch from pharmacy to general sales list status and leveraging the power of real-world data are two ways in which the UK's switch system can be made more efficient, according to the PAGB's new senior director of Regulatory Affairs, Michelle Riddalls. 
Prescription To Otc Switch Regulation

Sunscreens, Sanitizers In Tootsie Roll And Other Novelty Packaging Recalled

FDA also imposes import alert on lip balms, hand sanitizers and sunscreens made by Ningbo HuiZe Commodity in Zhejiang, China. Alert subjects products to detention without physical examination at US international ports of entry.

OTC Drugs Recalls
See All

Business Explore this Topic

Set Alert for Business {Health}

Latest From Deals & Health

Stada ‘Continuously Evaluating’ OTC Deals As Sales Grow Double Digits

Stada tells HBW Insight it remains on the lookout for deals despite only last month closing the acquisition of a basket of OTC brands from GSK. The German firm revealed its plans as it reported a double-digit rise in both sales and earnings at its Branded Products business for the opening six months of 2019.
Business Strategies Sales & Earnings

Hermes Grows In Germany With Krewel's OTC Portfolio

Hermes Arzneimittel will grow its share of Germany's OTC market by snapping up a portfolio of consumer health lines from Krewel Meuselbach.
Germany Health

Infant Formula Woes Turn Perrigo's Q2 Sour Despite Solid Americas’ OTC Sales

Perrigo reports 4% Q2 sales growth for OTC drugs in the Americas region was offset by nearly 15% drop in infant formula sale. Total consumer sales in the Americas slipped 2.5% to $582m, but CEO Murray Kessler says brighter days are ahead on benefits from Ranir oral care acquisition.

Sales & Earnings OTC Drugs
See All

Latest From Business Strategies & Health

NRT Delivery Innovation Proposal In US Doesn't Deliver Expanded Indications

GSK's proposed usage for mouth spray product – reducing withdrawal symptoms, including nicotine craving – differs little from the first NRT product approved in US in 1984. Additional suggested label instructions primarily focus on stating NRTs can be used to reduce smoking or gradually stop tobacco use as opposed to quitting within a specified amount of time.

OTC Drugs Regulation

Stada ‘Continuously Evaluating’ OTC Deals As Sales Grow Double Digits

Stada tells HBW Insight it remains on the lookout for deals despite only last month closing the acquisition of a basket of OTC brands from GSK. The German firm revealed its plans as it reported a double-digit rise in both sales and earnings at its Branded Products business for the opening six months of 2019.
Business Strategies Sales & Earnings

Consumer Health Executive Decisions: Karp Directs CHPA Health Policy, Pink's Husband Inspires CBD Line, More

Marina Karp joins CHPA as its first director of health policy; UFC welterweight Colby Covington signs on with Cannafornia CBD; "body activist" Ashley Graham is an Olly Nutrition brand ambassador; and Pink's husband, Carey Hart, inspires Next Green Wave's CBD line.

Canada United States
See All

Latest From Sales & Earnings & Health

Stada ‘Continuously Evaluating’ OTC Deals As Sales Grow Double Digits

Stada tells HBW Insight it remains on the lookout for deals despite only last month closing the acquisition of a basket of OTC brands from GSK. The German firm revealed its plans as it reported a double-digit rise in both sales and earnings at its Branded Products business for the opening six months of 2019.
Business Strategies Sales & Earnings

Consumer Health Results Roundup: Genomma, Ipsen And Taisho

Mexico's Genomma enjoys good growth in the second quarter, while Japan's Taisho records a steady start to its new financial year. Meanwhile, France's Ipsen endures a difficult period as its biggest OTC brand falters.
Sales & Earnings OTC Drugs

Infant Formula Woes Turn Perrigo's Q2 Sour Despite Solid Americas’ OTC Sales

Perrigo reports 4% Q2 sales growth for OTC drugs in the Americas region was offset by nearly 15% drop in infant formula sale. Total consumer sales in the Americas slipped 2.5% to $582m, but CEO Murray Kessler says brighter days are ahead on benefits from Ranir oral care acquisition.

Sales & Earnings OTC Drugs
See All

Latest From Legal Issues & Health

Bayer Stands By Iberogast As German Court Investigates Manslaughter Case

Bayer's Iberogast is in the spotlight in Germany. According to media reports, a German court is investigating a 2018 Iberogast-related death as a possible case of manslaughter and bodily harm caused by negligence. Bayer is standing behind its product, stating that the death was “most probably” due to an “idiosyncratic reaction.”  

Health OTC Drugs

Application Deadline Ordered To Stop Vaping Industry Evasion Of FDA Approval

"Balancing the need to address the existing public health crisis among today’s youth ... and the need to avoid creating an additional public health crisis if e-cigarette availability dropped so precipitously as to push users to combusted tobacco products," Judge Paul Grimm sets a May 2020 PMTA deadline for vaping products, noting the industry’s "lack of effort to obtain approval without an imminent deadline."

OTC Drugs FDA

GSK Admits Voltaren Marketing Misled Australian Consumers, Now Facing Financial Penalty

GSK has admitted misleading Australian consumers with the marketing of its Voltaren range by claiming Osteo Gel was specifically formulated for treating osteoarthritis conditions, and was more effective than Emulgel to treat those conditions, when the two products were identically formulated. While a change to Osteo Gel's packaging has since satisfied Australia's Federal Court, GSK is still facing a financial penalty for its earlier conduct.
Legal Issues Ad Campaigns
See All

Marketing Explore this Topic

Set Alert for Marketing {Health}

Latest From Launches & Health

Consumer Health Executive Decisions: Karp Directs CHPA Health Policy, Pink's Husband Inspires CBD Line, More

Marina Karp joins CHPA as its first director of health policy; UFC welterweight Colby Covington signs on with Cannafornia CBD; "body activist" Ashley Graham is an Olly Nutrition brand ambassador; and Pink's husband, Carey Hart, inspires Next Green Wave's CBD line.

Canada United States

Health And Wellness Product Trademark Review 13 August, 2019

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
OTC Drugs Dietary Supplements

TheOTCLab Looks To Gain A Foothold In Europe's OTC Market With FungeX

Beginning with its home market, the Netherlands, and also France, consumer healthcare specialist TheOTCLab is looking to establish a pan-European presence in the region's foot-care market with its new FungeX range of nail fungus and athletes' foot products. 
Launches France
See All

Latest From Ad Campaigns & Health

TheOTCLab Looks To Gain A Foothold In Europe's OTC Market With FungeX

Beginning with its home market, the Netherlands, and also France, consumer healthcare specialist TheOTCLab is looking to establish a pan-European presence in the region's foot-care market with its new FungeX range of nail fungus and athletes' foot products. 
Launches France

Stada Helps UK Eczema Sufferers Rebuild Confidence With Cetraben

Aimed at rebuilding the confidence of eczema sufferers, Stada Arzneimittel's 'Skinspirational' campaign for its medicated skin-care brand Cetraben enters its second phase with a new video and line extension. 
Health OTC Drugs

Bausch Sees Sales Drivers In Lumify, Ocuvite And PreserVision Line Extensions

Lumify reached 35% market share in US OTC eye drops and Ocuvite and Preservision vision health supplements are the No. 2 sales driver across Bausch's total portfolio.
OTC Drugs Dietary Supplements
See All

Latest From Ad Complaints & Health

Sonicare 'Charging Case' Comparison To Oral-B Loses Spark In Ad Review Appeal

Council of Better Business Bureaus appeals board agrees with all but one recommendation NAD made in review of claims for Philips' Sonicare DiamondClean power toothbrush challenged by P&G. In appeal by both firms, panel disagreed with investigative arm on comparative claim about toothbrush travel cases.

OTC Drugs Ad Complaints

Perrigo Rapped Over Solpadeine Claim in UK, While Cleared Of Wrongdoing In Spanish XLS Ad

Perrigo has found itself in hot water with the UK's MHRA over claims made on the website of its Solpadeine pain-relief brand. Meanwhile, the company has been exonerated after complaints against a TV ad to promote its XLS weight-loss brand proved to be unfounded.
Ad Complaints Spain

Sanofi Warned Over Use Of Social Media Influencer For UK Ad Campaign

Sanofi's decision to promote its Phenergan sleep-aid through a social media influencer - even one with a relatively small following - was tantamount to a celebrity endorsement, says the UK's advertising regulator.
Ad Complaints Ad Campaigns
See All
UsernamePublicRestriction

Register